MBL assays were performed at baseline in 1037 (91%) of the 1142 subjects enrolled in the azithromycin trial. Of these, 909 had experienced one or more AECOPDs in the year prior to enrollment. Duplicate measurements of MBL had coefficients of variations ,15% in all cases and ,5% in most.